Motor phenotype of LRRK2-associated Parkinson's disease: a longitudinal study

被引：0
|
作者：
Nabli, F. [1 ]
Ben Sassi, S. [1 ]
Hentati, E. [1 ]
Lakhdhar, I. [1 ]
Nahdi, H. [1 ]
Amouri, R. [1 ]
Hentati, F. [1 ]
机构：
[1] Natl Inst Neurol, Tunis, Tunisia
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [21] The Age at Motor Symptoms Onset in LRRK2-Associated Parkinson's Disease is Affected by a Variation in the MAPT Locus: A Possible Interaction
    Ziv Gan-Or
    Anat Bar-Shira
    Anat Mirelman
    Tanya Gurevich
    Nir Giladi
    Avi Orr-Urtreger
    Journal of Molecular Neuroscience, 2012, 46 : 541 - 544
  • [22] Immunomodulatory properties of hempseed oligopeptides in an LRRK2-associated Parkinson's disease animal model
    Torrecillas-Lopez, Maria
    Rivero-Pino, Fernando
    Trigo, Paula
    Toscano-Sanchez, Rocio
    Gonzalez-De la Rosa, Teresa
    Villanueva, Alvaro
    Millan-Linares, M. Carmen
    Montserrat-De la Paz, Sergio
    Claro-Cala, Carmen M.
    Food and Function, 2024, 15 (22): : 11115 - 11128
  • [23] Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease?
    Rudenko, Iakov N.
    Chia, Ruth
    Cookson, Mark R.
    BMC MEDICINE, 2012, 10
  • [24] Comparing Rates of Motor Progression before and after DBS among Patients with Idiopathic and LRRK2-Associated Parkinson's Disease
    Viser, Aaron C.
    Leaver, Katherine
    Miravite, Joan
    Kopell, Brian H.
    Ortega, Robert
    Raymond, Deborah
    Bressman, Susan B.
    Saunders-Pullman, Rachel
    San Luciano, Marta
    ANNALS OF NEUROLOGY, 2020, 88 : S181 - S181
  • [25] Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson's Disease
    Pchelina, S. N.
    Emelyanov, A. K.
    Yakimovskii, A. F.
    Miller, D. W.
    Shabalina, I. G.
    Drozdova, A. S.
    Schwarzman, A. L.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2011, 150 (06) : 679 - 681
  • [26] Does Uncoupling Protein 2 Expression Qualify as Marker of Disease Status in LRRK2-Associated Parkinson's Disease?
    Gruenewald, Anne
    Arns, Bjoern
    Meier, Britta
    Brockmann, Kathrin
    Tadic, Vera
    Klein, Christine
    ANTIOXIDANTS & REDOX SIGNALING, 2014, 20 (13) : 1955 - 1960
  • [27] Reduced Content of α-Synuclein in Peripheral Blood Leukocytes of Patients with LRRK2-Associated Parkinson’s Disease
    S. N. Pchelina
    A. K. Emelyanov
    A. F. Yakimovskii
    D. W. Miller
    I. G. Shabalina
    A. S. Drozdova
    A. L. Schwarzman
    Bulletin of Experimental Biology and Medicine, 2011, 150 : 679 - 681
  • [28] The genetic and clinical phenotype of LRRK2-associated familial PD
    Carol Lovegrove
    Nature Clinical Practice Neurology, 2006, 2 (3): : 125 - 125
  • [29] Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease
    Weykopf, Beatrice
    Haupt, Simone
    Jungverdorben, Johannes
    Flitsch, Lea Jessica
    Hebisch, Matthias
    Liu, Guang-Hui
    Suzuki, Keiichiro
    Belmonte, Juan Carlos Izpisua
    Peitz, Michael
    Blaess, Sandra
    Till, Andreas
    Bruestle, Oliver
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (04) : 561 - 589
  • [30] Clinical traits of LRRK2-associated Parkinson's disease in Ireland:: A link between familial and idiopathic PD
    Gosal, D
    Ross, OA
    Wiley, J
    Irvine, GB
    Johnston, JA
    Toft, M
    Mata, IF
    Kachergus, J
    Hulihan, M
    Taylor, JP
    Lincoln, SJ
    Farrer, MJ
    Lynch, T
    Gibson, JM
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (06) : 349 - 352
12345